These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 15977960)

  • 21. Utility of the Millon Behavioral Medicine Diagnostic (MBMD) to predict adherence to highly active antiretroviral therapy (HAART) medication regimens among HIV-positive men and women.
    Cruess DG; Minor S; Antoni MH; Millon T
    J Pers Assess; 2007 Dec; 89(3):277-90. PubMed ID: 18001228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Supporting adherence to highly active antiretroviral therapy and protected sex among people living with HIV/AIDS: the role of patient-provider communication in Rio de Janeiro, Brazil.
    Fehringer J; Bastos FI; Massard E; Maia L; Pilotto JH; Kerrigan D
    AIDS Patient Care STDS; 2006 Sep; 20(9):637-48. PubMed ID: 16987050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patients and family care givers' experiences around highly active antiretroviral therapy (HAART).
    Sacajiu G; Raveis VH; Selwyn P
    AIDS Care; 2009 Dec; 21(12):1528-36. PubMed ID: 20024732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adherence to antiretroviral therapy for pediatric HIV infection: a qualitative systematic review with recommendations for research and clinical management.
    Simoni JM; Montgomery A; Martin E; New M; Demas PA; Rana S
    Pediatrics; 2007 Jun; 119(6):e1371-83. PubMed ID: 17533177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measuring adherence to highly active antiretroviral therapy: implications for research and practice.
    Kerr T; Walsh J; Lloyd-Smith E; Wood E
    Curr HIV/AIDS Rep; 2005 Nov; 2(4):200-5. PubMed ID: 16343379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa.
    Reddi A; Leeper SC; Grobler AC; Geddes R; France KH; Dorse GL; Vlok WJ; Mntambo M; Thomas M; Nixon K; Holst HL; Karim QA; Rollins NC; Coovadia HM; Giddy J
    BMC Pediatr; 2007 Mar; 7():13. PubMed ID: 17367540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abacavir compared to protease inhibitors as part of HAART regimens for treatment of HIV infection: patient satisfaction and implications for adherence.
    Jordan J; Cahn P; Goebel F; Matheron S; Bradley C; Woodcock A
    AIDS Patient Care STDS; 2005 Jan; 19(1):9-18. PubMed ID: 15665631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sustained antiretroviral treatment adherence in survivors of the pre-HAART era: attitudes and beliefs.
    Fumaz CR; Muñoz-Moreno JA; Moltó J; Ferrer MJ; López-Blázquez R; Negredo E; Paredes R; Gómez G; Clotet B
    AIDS Care; 2008 Aug; 20(7):796-805. PubMed ID: 18728987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adherence to antiretroviral therapy in children attending Mulago Hospital, Kampala.
    Nabukeera-Barungi N; Kalyesubula I; Kekitiinwa A; Byakika-Tusiime J; Musoke P
    Ann Trop Paediatr; 2007 Jun; 27(2):123-31. PubMed ID: 17565809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adherence to HAART among patients with HIV: breakthroughs and barriers.
    Ickovics JR; Meade CS
    AIDS Care; 2002 Jun; 14(3):309-18. PubMed ID: 12042076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Adherence to antiretroviral therapy during HIV infection, a multidisciplinary approach].
    Slama L; Le Camus C; Amiel C; Pialoux G; Gharakhanian S
    Med Mal Infect; 2006 Jan; 36(1):16-26. PubMed ID: 16325363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Once-daily highly active antiretroviral therapy for HIV-infected children: safety and efficacy of an efavirenz-containing regimen.
    Scherpbier HJ; Bekker V; Pajkrt D; Jurriaans S; Lange JM; Kuijpers TW
    Pediatrics; 2007 Mar; 119(3):e705-15. PubMed ID: 17308244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strategies for improving patient adherence to therapy and long-term patient outcomes.
    Battaglioli-DeNero AM
    J Assoc Nurses AIDS Care; 2007; 18(1 Suppl):S17-22. PubMed ID: 17275718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between routinization of daily behaviors and medication adherence in HIV-positive drug users.
    Wagner GJ; Ryan GW
    AIDS Patient Care STDS; 2004 Jul; 18(7):385-93. PubMed ID: 15307927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy.
    Bouhnik AD; Préau M; Vincent E; Carrieri MP; Gallais H; Lepeu G; Gastaut JA; Moatti JP; Spire B;
    Antivir Ther; 2005; 10(1):53-61. PubMed ID: 15751763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of adherence to antiretroviral medications in children and adolescents with HIV infection.
    Williams PL; Storm D; Montepiedra G; Nichols S; Kammerer B; Sirois PA; Farley J; Malee K;
    Pediatrics; 2006 Dec; 118(6):e1745-57. PubMed ID: 17101712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intention to adhere to HIV treatment: a patient-centred predictor of antiretroviral adherence.
    Nelsen A; Gupta S; Trautner BW; Petersen NJ; Garza A; Giordano TP; Naik AD; Rodriguez-Barradas MC
    HIV Med; 2013 Sep; 14(8):472-80. PubMed ID: 23551395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Barriers to antiretroviral adherence among HIV-infected adults.
    Murphy DA; Roberts KJ; Martin DJ; Marelich W; Hoffman D
    AIDS Patient Care STDS; 2000 Jan; 14(1):47-58. PubMed ID: 12240882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study.
    Roux P; Carrieri MP; Villes V; Dellamonica P; Poizot-Martin I; Ravaux I; Spire B;
    Addiction; 2008 Nov; 103(11):1828-36. PubMed ID: 18778390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adherence to combination antiretroviral treatment in children.
    Pontali E; Feasi M; Toscanini F; Bassetti M; De Gol P; Nuzzolese A; Bassetti D
    HIV Clin Trials; 2001; 2(6):466-73. PubMed ID: 11742434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.